Engerix-b pedi 10 MCG/0.5 syrn 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FDQXU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,578
Award facts
- Contract value 100% obligated
- $7,578.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccines. The award carries no set-aside designation and has an ultimate completion date of July 30, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. This delivery order represents one of many pharmaceutical supply contracts the company has secured through the DLA's procurement channels.
This award is issued under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and extending through November 2026. That overarching IDC authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains an extensive portfolio of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables that directly support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FDQXU?
SPE2DB25FDQXU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FDQXU worth?
The government has obligated $7,578 on SPE2DB25FDQXU.
Is contract SPE2DB25FDQXU an order under another contract?
Yes. SPE2DB25FDQXU is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQXU competed?
The extent of competition for SPE2DB25FDQXU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award